monitoring and reporting quality performance and medication safety in community pharmacy
Download
Skip this Video
Download Presentation
Monitoring and Reporting Quality Performance and Medication Safety in Community Pharmacy

Loading in 2 Seconds...

play fullscreen
1 / 14

Monitoring and Reporting Quality Performance and Medication Safety in Community Pharmacy - PowerPoint PPT Presentation


  • 139 Views
  • Uploaded on

Monitoring and Reporting Quality Performance and Medication Safety in Community Pharmacy. Overview. This educational material is to assist you in viewing and interpreting your pharmacy performance reports as part of the Purdue University demonstration project.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Monitoring and Reporting Quality Performance and Medication Safety in Community Pharmacy' - adrina


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
monitoring and reporting quality performance and medication safety in community pharmacy
Monitoring and Reporting Quality Performance and Medication Safety in Community Pharmacy
overview
Overview
  • This educational material is to assist you in viewing and interpreting your pharmacy performance reports as part of the Purdue University demonstration project.
  • After reading this material, proceed to your individual store pharmacy quality measures (Your Pharmacy Quality Measures link). View your results and let the investigators know if you have any questions using the “Contact Us” link.
  • When you have viewed your individual store report, complete the feedback survey to let the investigators know your thoughts on the website.
assessing health care quality

Patient

Provider

Payer

Assessing Health Care Quality

Concerns about quality are different based on the stakeholders. Stakeholders may have different, as well as overlapping priorities in regards to quality. However, a high quality system must be:

  • safe
  • effective
  • patient-centered
  • timely
  • efficient
  • equitable

Reprinted with permission of .PQA. Warholak, West, and Holdford, EPIQ program, 2008.

changing to a high quality health care system
Changing to a High Quality Health Care System

Many different organizations are changing the quality of the Health Care System:

Evidence-based Medicine:

Guideline Developers:

  • Associations
  • AHA/ACC
  • AMA
  • (Many others!)
  • ADA
  • AHA

Guideline Development

Measure

Development

  • NCQA
  • JCAHO
  • AHRQ
  • Health Plans
  • Prof. Associations
    • AHA/ACC
  • Others (PQA)

Measure

Endorsement

National Quality Forum (NQF) Consensus Development Process

Measure Selection for Public

Reporting, Pay for Reporting

Pay for Performance

  • CMS, AHRQ
  • Alliances(HQA, AQA, PQA)
  • The LeapFrog Group
  • Bridges to Excellence
  • Other collaborative P4P/P4R
pharmacy performance measures

Patient Compliance rates

Optimal asthma therapy

Optimal diabetes care management

Appropriate medications for the elderly

Patient satisfaction-clinical care oriented

Today

Pharmacy Performance Measures
  • Number of prescriptions filled/day
  • Generic conversion
  • Prescriptions filled per unit of time
  • Labor Cost per prescription
  • Rx sales
  • New/Refill prescription ratio
  • Patient Satisfaction – convenience oriented

Future

Expanding Measurement to focus on “Quality of Pharmacy Services” will help to promote the pharmacist as a key patient care provider who assures appropriate medication use.

Reprinted with permission of .PQA. Warholak, West, and Holdford, EPIQ program, 2008.

pharmacy quality alliance pqa
Pharmacy Quality Alliance (PQA)
  • Includes over 60 member organizations in the U.S.
  • Started by a collaborative of the federal government (CMS*) and private organizations (ie. AHIP**) a with the goal to develop and report quality/efficiency measures of pharmacy/pharmacists services.
  • Is a membership-based, self-sustaining, consensus-driven, organization.
  • Funded 5 demonstration projects to determine the feasibility of using a starter set of expanded quality performance measures of pharmacy services.

*Center for Medicare and Medicaid Services

**America’s Health Insurance Plans

demonstration project
Demonstration Project
  • Purdue University received funding from PQA for a demonstration project focused on central Indiana community pharmacies.
  • Project consists of:
    • PQA Developed and Endorsed Quality Performance Measures.
    • Retrospective analysis of prescription claims data.
    • Patient experience (satisfaction) survey.
    • Web-based performance reports.
  • For this project:
    • All quality reports are password protected and confidential.
    • Authorized pharmacists only can view their own pharmacy reports.
    • Reports do NOT affect individual or store performance evaluations.
pqa endorsed performance measures
PQA Endorsed Performance Measures
  • Proportion  of  Days  Covered  (PDC)
    • Percent of patients who met threshold of 80 percent or have medication available to them for 80% of the days covered by the prescription
    • Reported for:  Beta  Blockers , ACEI/ARB, Calcium Channel Blockers, Dyslipidemia Medications, Diabetes Mediations  (Sulfonylureas, Biguanides, TZDs)
  • Gap  in  Therapy
    • Percent of patients who were dispensed at least 2 prescriptions in a specific therapeutic category who experienced a gap in medication therapy of greater than or equal to 30 days
    • Reported for: Beta  Blockers , ACEI/ARB, Calcium Channel Blockers, Dyslipidemia Medications, Diabetes Mediations  (Sulfonylureas, Biguanides, TZDs)
  • Diabetes:  Excessive  Doses  of  Oral  Medications
    • Percent of patients who were dispensed a dose higher than the daily recommended dose for biguanides, sulfonlyureas, and thiazolidinediones
pqa endorsed performance measures cont
PQA Endorsed Performance Measures Cont.
  • Diabetes:  Suboptimal  Treatment  of  Hypertension
    • Percent of patients who were dispensed a medication for diabetes and hypertension who are not receiving an ACEI or ARB medication
  • Asthma:   Suboptimal  Control
    • Percent of patients with persistent asthma who were dispensed more than 5 canisters of a short acting beta2 agonist inhaler during the same 3 month period
  • Asthma:   Absence  of  Controller  Therapy
    • Percent of patients with persistent asthma who were dispensed more than 5 canisters of short acting beta2 agonist inhalers over a 90 day period who did not receive controller therapy during the same 90-day period
how is the data obtained for the performance measure reports
How is the data obtained for the performance measure reports

Pharmacy Store

Store ReportCards

Rx Claims

Pharmacy Store

Store ReportCards

Payer Data regarding

Rx Claims

Regenstrief Institute

Data Analysis

Pharmacy Store

Store ReportCards

Rx Claims

Pharmacy Store

Store ReportCards

performance report website http www indianapharmacycompare org
Performance Report Website: http://www.IndianaPharmacyCompare.org

If you have questions or comments

Survey to report your opinions of the website

Measurement Period

Pull-down to see your store characteristics (demographics)

Estimate of the percent of patients qualifying for the measure that only used your store for prescriptions of this medication type

performance report website http www indianapharmacycompare org1
Performance Report Website:http://www.IndianaPharmacyCompare.org

Your store performance (number of patient meeting criteria/potential patients eligible)

Describes the desired outcome

Pull-down to see definitions

Denotes an improvement opportunity or individual store percentage does not meet the average

Individual store ranking based on participating pharmacies

i have seen the performance measures now what
I have seen the performance measures. Now what?
  • What are ways to improve compliance?
    • Identify patients with late refills and discuss any concerns
    • Develop “registries” of patients that are late to refill
    • Telephone, mail, email, text contacts for reminders
  • What are ways to improve therapy?
    • Offer services such as “brown bag” discussions
    • Use your employer’s innovative programs
    • Pay attention to alerts and act on them
  • Simplify drug regimens
    • Change medication dosing to “once daily” if possibleAct on therapy duplicates
    • Contact physicians when patient therapy could be maximized
i have seen the performance measures and i have questions
I have seen the performance measures and I have questions

Kimberly S. Plake, PhD, RPh

Purdue University

(765) 494-5966

[email protected]

Carol Birk, MS, RPh

PharmaTAP

(317) 698-9026

[email protected]

ad